286 related articles for article (PubMed ID: 25053392)
1. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
Zouré HG; Noma M; Tekle AH; Amazigo UV; Diggle PJ; Giorgi E; Remme JH
Parasit Vectors; 2014 Jul; 7():326. PubMed ID: 25053392
[TBL] [Abstract][Full Text] [Related]
2. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.
Noma M; Zouré HG; Tekle AH; Enyong PA; Nwoke BE; Remme JH
Parasit Vectors; 2014 Jul; 7():325. PubMed ID: 25053266
[TBL] [Abstract][Full Text] [Related]
3. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).
Noma M; Nwoke BE; Nutall I; Tambala PA; Enyong P; Namsenmo A; Remme J; Amazigo UV; Kale OO; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S29-39. PubMed ID: 12081248
[TBL] [Abstract][Full Text] [Related]
4. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
5. Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei sl is the vector.
Katabarwa M; Onapa AW; Nakileza B
East Afr Med J; 1999 Aug; 76(8):440-6. PubMed ID: 10520349
[TBL] [Abstract][Full Text] [Related]
6. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.
Murdoch ME; Asuzu MC; Hagan M; Makunde WH; Ngoumou P; Ogbuagu KF; Okello D; Ozoh G; Remme J
Ann Trop Med Parasitol; 2002 Apr; 96(3):283-96. PubMed ID: 12061975
[TBL] [Abstract][Full Text] [Related]
9. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
10. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC).
Sékétéli A; Adeoye G; Eyamba A; Nnoruka E; Drameh P; Amazigo UV; Noma M; Agboton F; Aholou Y; Kale OO; Dadzie KY
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S15-28. PubMed ID: 12081247
[TBL] [Abstract][Full Text] [Related]
11. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
12. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
[TBL] [Abstract][Full Text] [Related]
13. Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon.
Macé JM; Boussinesq M; Ngoumou P; Enyegue Oye J; Koéranga A; Godin C
Ann Trop Med Parasitol; 1997 Jun; 91(4):379-91. PubMed ID: 9290845
[TBL] [Abstract][Full Text] [Related]
14. The African Programme for Onchocerciasis Control (APOC).
Amazigo U
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
[TBL] [Abstract][Full Text] [Related]
15. Mapping the burden of onchocercal skin disease.
Murdoch ME
Br J Dermatol; 2021 Feb; 184(2):199-207. PubMed ID: 32302410
[TBL] [Abstract][Full Text] [Related]
16. Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.
Abanobi OC; Anosike JC
Public Health; 2000 Sep; 114(5):402-6. PubMed ID: 11035465
[TBL] [Abstract][Full Text] [Related]
17. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
Coffeng LE; Stolk WA; Zouré HG; Veerman JL; Agblewonu KB; Murdoch ME; Noma M; Fobi G; Richardus JH; Bundy DA; Habbema D; de Vlas SJ; Amazigo UV
PLoS Negl Trop Dis; 2013; 7(1):e2032. PubMed ID: 23383355
[TBL] [Abstract][Full Text] [Related]
18. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
[TBL] [Abstract][Full Text] [Related]
19. The Mectizan Donation Program (MDP).
Thylefors B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
Duerr HP; Eichner M
Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]